African Congress for Clinical Trials
Lambaréné, 10-14 November 2019 (2nd edition)
Clinical trial in Sub-saharan Africa : Challenge or Opportunity ?
Peter Gottfried Kremsner is a medical doctor, specialized in infectious diseases and tropical medicine. He is full professor and Director of the Institute of Tropical Medicine at the University of Tübingen, Germany. Since 1992, he has been the natural leader of the ‘Centre de Recherches Médicales de Lambaréné’ (CERMEL), in Gabon. He is currently the President of CERMEL's Board of Trustees.
Prof Kremsner is author and co-author of more than 600 scientific publications. He has led numerous clinical trials in Africa on infectious diseases, inter alia studies focusing on the development of atovaquone/proguanil, artesunate/amodiaquine, artesunate/pyronaridine, artesunate parenteral treatment, as well as malaria prophylaxis.
Under his supervision, a research team working with the company Sanaria Inc. is developing a new vaccine based on PfSPZ.
Prof Kremsner and his ‘Lambaréné-Tübingen’ team have also established a model for Controlled Human Malaria Infection (CHMI). The use of this CHMI model significantly reduces the time required for antimalarial drug and vaccine development.
Prof Kremsner is committed to make ACCT become a major scientific meeting in Africa.